Lasers and Light Sources for Medical Dermatologic Conditions
Lasers and light sources have become more commonplace in the treatment of dermatologic medical diseases.
ALA-PDT is a proven therapy for actinic keratoses and superficial non-melanoma skin cancers.
ALA-PDT is being used to treat the signs of photorejuvenation with a variety of vascular lasers, blue light sources, and the intense pulsed light source.
PDT is a useful therapy for acne vulgaris with blue light and other light sources as well.
ALA-PDT is being used to treat moderate to severe acne vulgaris, andother sebaceous gland disorders with a variety of vascular lasers, blue light sources, and the intense pulsed light source.
New lasers and light sources are being used to treat psoriasis vulgaris, vitiligo, other disorders of pigmentation, and hypopigmented stretch marks.
KeywordsSebaceous Gland Intense Pulse Light Hidradenitis Suppurativa Acne Lesion Inflammatory Acne
History of Photodynamic Therapy
- Jesionek A, Von Tappeiner H (1905) Behandlung der Hautcarcinome nut fluorescierenden Stoffen. Dtsch Arch Klin Med 85:223–227Google Scholar
- McCaughan JS Jr, Brown DG, Hawley PC (1992) Photodynamic therapy: an eight year experience. In: Henderson BW, Dougherty TJ (eds) Photodynamic therapy: basic principle and clinical application. Marcel Dekker, New York, pp 323–331Google Scholar
- Pass HI, Delaney TF (1992) Innovative photodynamic therapy at the National Cancer Institute: intraoperative intracavity treatment. In: Henderson BW, Dougherty TJ (eds) Photodynamic therapy: basic principle and clinical application. Marcel Dekker, New York, pp 287–301Google Scholar
- Ratkay LB, Chowdhary RK, Damaroon A, Richter AM, Neyndorff HC, Keystone EC et al (1998) Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy. Arthritis Rheum 41:525–543PubMedCrossRefGoogle Scholar
- Von Tappeiner H, Jodblauer A (1904) Ubner die Wirkung der photodynamischen (fluorescierenden) Staffe auf Protozoen und Enzyme. Dtsch Arch Klin Med 80:427–487Google Scholar
U.S. Experience for Actinic Keratoses with ALA-PDT
New U.S. Indications for Photodynamic Photorejuvenation with ALA-PDT
- Avram D, Goldman MP (2004) Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 3(S):36–39Google Scholar
- Bissonnette R, Bergeson A, Lui H (2004) Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol 3(S):26–31Google Scholar
- Gold MH. Intense pulsed light therapy for photorejuvenation enhanced with 20% aminolevulinic acid photodynamic therapy. J Laser Med Surg. 2003;15(S):47.Google Scholar
- Goldman MP, Atkin D, Kincad S (2002) PDT/ALA in the treatment of actinic damage: real world experience. J Lasers Med Surg 14(S):24Google Scholar
- Key DJ (2005) Aminolevulinic acid-pulsed dye laser photodynamic therapy for the treatment of photoaging. Cosmet Dermatol 18:31–36Google Scholar
The European and Early USA Experience for Actinic Keratoses and Skin Cancers
- Kashe A, Luderschmidt S, Ring J et al (2006) Photodynamic therapy induces less pain in patients treated with methyl aminolaevulinate compared to aminolaevulinate acid. J Drugs Dermatol 5(4):353–356Google Scholar
- Wiegell SW, Wulf HC (2006) Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolaevulinate. J Am Acad Dermatol 54:647–651Google Scholar
Photodynamic Therapy for Acne Vulgaris
- (no authors) (2003) Med Lett Drug Ther 45(1159):50–51Google Scholar
- Gold MH. The utilization of ALA-PDT and a new photoclearing device for the treatment of severe inflammatory acne vulgaris – results of an initial clinical trial. J Lasers Surg Med. 2003;15(S):46.Google Scholar
- Gold MH. A multi-center investigatory study of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. J Am Acad Dermatol. 2004;50(S):56.Google Scholar
- Gold, MH. A multi-center study of photodynamic therapy in the treatment of moderate to severe inflammatory acne vulgaris with topical 20% 5-aminolevulinic acid and a new intense pulsed light source. J Am Acad Dermatol. 2004;50(S):54.Google Scholar
- Goldman MP (2003) Using 5-aminolevulinic acid to treat acne and sebaceous hyperplasia. Cosmet Dermatol 16:57–58Google Scholar
- Wiegell SR, Wulf HC (2006) Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized controlled trial. Br J Dermatol 154:969–976Google Scholar
Photodynamic Therapy for Hidradenitis Suppurativa
- Gold MH, Bridges T, Bradshaw V et al (2004) ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol 3(S):32–39Google Scholar
Photodynamic Therapy for Sebaceous Gland Hyperplasia
- Gold MH. A single center, open label investigator study of photodynamic therapy in the treatment of sebaceous gland hyperplasia with topical 20% 5-aminolevulinic acid with visible blue light or intense pulsed light. J Am Acad Dermatol. 2004;50(S):638.Google Scholar
- Richey DF, Hopson B. Treatment of sebaceous hyperplasia by photodynamic therapy. Personal communication 03/04.Google Scholar
Currently Available Technology
- Tanghetti E. Personal communication 2002.Google Scholar